Skip to content

Taxes Paid at other companies

Regenxbio logo
RegenxbioRGNX
$71.25K+496%
Xencor logo
XencorXNCR
$3.01M
Schrodinger logo
SchrodingerSDGR
$266K+91.4%
Nuvation Bio logo
Nuvation BioNUVB
$49.25K-47.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$11.66M+16,554%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$351K-8,875%

Other financials

Income statement

See full
Revenue$14.5M-16.5%
Operating income-$29.7M+56.7%
Net income-$38.5M+49.3%
EPS (diluted)-$2.94+67.6%

Balance sheet

See full
Cash & equivalents$73.7M-30.6%
Total debt$13.6M-36.3%
Total equity-$66.9M-159%
Total assets$242.0M-24.7%

Cash flow

See full
Operating cash flow-$42.3M+37.7%
CapEx--100%
Free cash flow-$42.3M+37.8%

Valuation

See full
Market cap$489.66M+624%
Enterprise value$429.61M-2,600%
P/S4.9×+3.9×

Profitability

See full
Operating margin-120%-48.6pp
Net margin-154.2%-56.7pp
FCF margin-152.2%-51.1pp

Returns & leverage

See full
Return on equity-234.2%
Debt / equity0.5×+0.3×
Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sutro Biopharma's taxes paid?
Sutro Biopharma (STRO) reported taxes paid of -$15K in Q1 2026.
How has Sutro Biopharma's taxes paid changed year-over-year?
Sutro Biopharma's taxes paid decreased by 314.3% year-over-year, from $7K to -$15K.
What is the long-term trend for Sutro Biopharma's taxes paid?
Over 4 years (2021 to 2025), Sutro Biopharma's taxes paid has grown at a -7.6% compound annual growth rate (CAGR), from $103K to $75K.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.